@prefix ns1: <http://linked.opendata.cz/ontology/drug-encyclopedia/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xml: <http://www.w3.org/XML/1998/namespace> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<http://linked.opendata.cz/resource/ATC/C01EB10> a ns1:ATCConcept ;
    skos:notation "C01EB10" ;
    skos:prefLabel "Adenosin"@cs,
        "Adenosine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/ingredient/M0000377> a ns1:Ingredient ;
    ns1:contraindicatedWith <http://linked.opendata.cz/resource/ndfrt/disease/N0000000507>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000508>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000000999>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000001879>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000002743>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003541> ;
    ns1:description "A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter.     "@en ;
    ns1:hasMechanismOfAction <http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000228> ;
    ns1:hasMedicinalProduct <http://linked.opendata.cz/resource/sukl/medicinal-product/ADENOCOR> ;
    ns1:hasPharmacologicalAction <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001067>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326>,
        <http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559> ;
    ns1:hasPhysiologicEffect <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009748>,
        <http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009764> ;
    ns1:hasPregnancyCategory <http://linked.opendata.cz/resource/fda-spl/pregnancy-category/C> ;
    ns1:mayPrevent <http://linked.opendata.cz/resource/ndfrt/disease/N0000002197> ;
    ns1:mayTreat <http://linked.opendata.cz/resource/ndfrt/disease/N0000002197>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000002889>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000002892>,
        <http://linked.opendata.cz/resource/ndfrt/disease/N0000003166> ;
    ns1:title "Adenosin"@cs,
        "Adenosine"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001067> a ns1:PharmacologicalAction ;
    ns1:description "Compounds capable of relieving pain without the loss of CONSCIOUSNESS.     "@en ;
    ns1:title "Analgetika"@cs,
        "Analgesics"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0001326> a ns1:PharmacologicalAction ;
    ns1:description "Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.     "@en ;
    ns1:title "Antiarytmika"@cs,
        "Anti-arrhythmia agents"@en .

<http://linked.opendata.cz/resource/drug-encyclopedia/pharmacological-action/M0022559> a ns1:PharmacologicalAction ;
    ns1:description "Drugs used to cause dilation of the blood vessels.     "@en ;
    ns1:title "Vasodilatancia"@cs,
        "Vasodilator agents"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000507> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.     "@en ;
    ns1:title "Fibrilace síní"@cs,
        "Atrial fibrillation"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000508> a ns1:DiseaseOrFinding ;
    ns1:description "Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).     "@en ;
    ns1:title "Flutter síní"@cs,
        "Atrial flutter"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000000999> a ns1:DiseaseOrFinding ;
    ns1:description "Immunologically mediated adverse reactions to medicinal substances used legally or illegally.     "@en ;
    ns1:title "Léková alergie"@cs,
        "Drug hypersensitivity"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000001879> a ns1:DiseaseOrFinding ;
    ns1:description "Pathological processes involving any part of the LUNG.     "@en ;
    ns1:title "Plicní nemoci"@cs,
        "Lung diseases"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002197> a ns1:DiseaseOrFinding ;
    ns1:description "A collective term for nutritional disorders resulting from poor absorption or nutritional imbalance, and metabolic disorders resulting from defects in biosynthesis (ANABOLISM) or breakdown (CATABOLISM) of endogenous substances.     "@en ;
    ns1:title "Výživa a metabolismus - nemoci"@cs,
        "Nutritional and metabolic diseases"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002743> a ns1:DiseaseOrFinding ;
    ns1:description "A condition caused by dysfunctions related to the SINOATRIAL NODE including impulse generation (CARDIAC SINUS ARREST) and impulse conduction (SINOATRIAL EXIT BLOCK). It is characterized by persistent BRADYCARDIA, chronic ATRIAL FIBRILLATION, and failure to resume sinus rhythm following CARDIOVERSION. This syndrome can be congenital or acquired, particularly after surgical correction for heart defects.     "@en ;
    ns1:title "Syndrom chorého sinu"@cs,
        "Sick sinus syndrome"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002889> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormally rapid heartbeats caused by reentry of atrial impulse into the dual (fast and slow) pathways of ATRIOVENTRICULAR NODE. The common type involves a blocked atrial impulse in the slow pathway which reenters the fast pathway in a retrograde direction and simultaneously conducts to the atria and the ventricles leading to rapid HEART RATE of 150-250 beats per minute.     "@en ;
    ns1:title "Atrioventrikulární nodální reentry tachykardie"@cs,
        "Tachycardia, atrioventricular nodal reentry"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000002892> a ns1:DiseaseOrFinding ;
    ns1:description "Abnormally rapid heartbeats with sudden onset and cessation.     "@en ;
    ns1:title "Paroxysmální tachykardie"@cs,
        "Tachycardia, paroxysmal"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003166> a ns1:DiseaseOrFinding ;
    ns1:description "A form of ventricular pre-excitation characterized by a short PR interval and a long QRS interval with a delta wave. In this syndrome, atrial impulses are abnormally conducted to the HEART VENTRICLES via an ACCESSORY CONDUCTING PATHWAY that is located between the wall of the right or left atria and the ventricles, also known as a BUNDLE OF KENT. The inherited form can be caused by mutation of PRKAG2 gene encoding a gamma-2 regulatory subunit of AMP-activated protein kinase.     "@en ;
    ns1:title "Wolffův-parkinsonův-whiteův syndrom"@cs,
        "Wolff-parkinson-white syndrome"@en .

<http://linked.opendata.cz/resource/ndfrt/disease/N0000003541> a ns1:DiseaseOrFinding ;
    ns1:description "An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).     "@en ;
    ns1:title "Komorová tachykardie"@cs,
        "Tachycardia, ventricular"@en .

<http://linked.opendata.cz/resource/ndfrt/mechanism-of-action/N0000000228> a ns1:MechanismOfAction ;
    ns1:title "Structural Macromolecules"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009748> a ns1:PhysiologicEffect ;
    ns1:title "Metabolic Activity Alteration"@en .

<http://linked.opendata.cz/resource/ndfrt/physiologic-effect/N0000009764> a ns1:PhysiologicEffect ;
    ns1:title "Nodal Repolarization"@en .

<http://linked.opendata.cz/resource/sukl/medicinal-product/ADENOCOR> a ns1:MedicinalProduct ;
    ns1:hasATCConcept <http://linked.opendata.cz/resource/ATC/C01EB10> ;
    ns1:title "ADENOCOR"@cs .


